Identifying and Treating Childhood Apraxia of Speech in Minimally Verbal Children with Autism
识别和治疗很少言语的自闭症儿童的儿童期言语失用症
基本信息
- 批准号:10123334
- 负责人:
- 金额:$ 6.7万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-09-01 至 2021-08-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Although one in four children with autism remain minimally verbal past age five, we do not know all
the factors that limit spoken language in these minimally verbal children with autism. One powerful
contributor may be a concomitant motor speech disorder, Childhood Apraxia of Speech (CAS). CAS
is an impairment in the ability to plan and sequence for speech, which renders speech inconsistent
and imprecise. But because producing intelligible speech is a prerequisite to acquiring spoken
language, there is an urgent need to understand how CAS may affect speech movements and
intelligibility in minimally verbal children with autism, and to develop interventions that incorporate
strategies to address CAS, when present. This project proposes three studies to investigate the
relationship between CAS and speech in minimally verbal children with autism and CAS. First, we
compare a group of 11 minimally verbal children with autism who meet criteria for CAS to a group of
11 who do not meet criteria for CAS. We hypothesize that facial movement tracking, a non-invasive
method to investigate speech motor function, will reveal that the +CAS group show lower movement
consistency and precision than the –CAS group. Next, we investigate the relationship of clinical signs
of CAS to speech movement parameters and to intelligibility. We hypothesize that more severe CAS
predicts lower movement consistency and precision, and lower intelligibility, in an additional group of
22 minimally verbal children with autism+CAS. Finally, we use the previous investigations to inform
treatment for a group of 20 minimally verbal children with autism+CAS. First we identify the speech
movements for each child that are both disordered and degrade intelligibility,. Then, we create a set
of mono- and bisyllabic stimuli involving these movements and train participants on a subset of them
in a series of single-subject experiments. Treatment will involve principles of motor learning (massed
and distributed practice) and dynamic cueing, which have been shown to be effective for treating
CAS. Both perceptual (intelligibility-based) and objective (movement-based) outcome measures will
demonstrate the extent to which this targeted treatment improves speech production in these
children. The findings will inform clinical practice for minimally verbal children with autism and lead to
the development of novel interventions for this severely affected population.
尽管四分之一的自闭症儿童过去五岁的言语仍然很少,但我们并不了解
在这些自闭症的最低言语儿童中限制口语的因素。一个强大的
贡献者可能是一种伴随的运动言语障碍,儿童言语失用(CAS)。 CAS
是计划和序列序列的损害,这使语音不一致
并暗示。但是因为发表可理解的演讲是获取口语的先决条件
语言,迫切需要了解CAS如何影响语音运动和
对自闭症自闭症的最低言语儿童的清晰性,并制定结合的干预措施
在场时解决CA的策略。该项目提出了三项研究,以调查
CAS与言语中的CAS与自闭症和CAS的言语之间的关系。首先,我们
比较一组11个最小口头的自闭症儿童,他们符合CAS的标准与一群
11谁不符合CAS的标准。我们假设面部运动跟踪是一种无创的
调查语音运动功能的方法,将揭示 +CAS组显示较低运动
一致性和精度比–CAS组。接下来,我们研究临床体征的关系
CAS到语音运动参数和清晰度。我们假设更严重的CAS
预测较低的运动一致性和精确度,并降低了一组
22个自闭症+CAS的最小口头儿童。最后,我们使用以前的调查通知
一组20个自闭症+CAS的最小口头儿童的治疗。首先,我们确定演讲
每个既无序和降解智力的孩子的运动。然后,我们创建一个集合
单声道和双音节刺激涉及这些运动,并在其中的一部分上训练参与者
在一系列单个受试者实验中。治疗将涉及运动学习原理(群众)
和分布式实践)和动态提示,这些提示已被证明有效治疗
CAS。感知(基于清晰度)和客观(基于运动)的结果度量都将
证明该靶向治疗在多大程度上改善了这些治疗的言语产生
孩子们。这些发现将为有自闭症的最低言语儿童提供临床实践,并导致
针对这一受到严重影响的人群的新干预措施的发展。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
KAREN V CHENAUSKY其他文献
KAREN V CHENAUSKY的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('KAREN V CHENAUSKY', 18)}}的其他基金
Identifying and Treating Childhood Apraxia of Speech in Minimally Verbal Children with Autism
识别和治疗很少言语的自闭症儿童的儿童期言语失用症
- 批准号:
10505099 - 财政年份:2019
- 资助金额:
$ 6.7万 - 项目类别:
Identifying and Treating Childhood Apraxia of Speech in Minimally Verbal Children with Autism
识别和治疗很少言语的自闭症儿童的儿童期言语失用症
- 批准号:
10382142 - 财政年份:2019
- 资助金额:
$ 6.7万 - 项目类别:
Identifying and Treating Childhood Apraxia of Speech in Minimally Verbal Children with Autism
识别和治疗很少言语的自闭症儿童的儿童期言语失用症
- 批准号:
10006328 - 财政年份:2019
- 资助金额:
$ 6.7万 - 项目类别:
Identifying and Treating Childhood Apraxia of Speech in Minimally Verbal Children with Autism
识别和治疗很少言语的自闭症儿童的儿童期言语失用症
- 批准号:
10531626 - 财政年份:2019
- 资助金额:
$ 6.7万 - 项目类别:
相似国自然基金
Galectin-3调控PD-L1在原发性肝细胞癌免疫治疗和预后中的作用及机制
- 批准号:82304216
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
FOXO3 m6A甲基化修饰诱导滋养细胞衰老效应在补肾法治疗自然流产中的机制研究
- 批准号:82305286
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
胶质瘤线粒体靶向纳米药物合成及其诱导免疫治疗效应的机制研究
- 批准号:82303810
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
靶向Treg-FOXP3小分子抑制剂的筛选及其在肺癌免疫治疗中的作用和机制研究
- 批准号:32370966
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
SHP2在骨髓增殖性肿瘤中的作用机制及其靶向治疗研究
- 批准号:82300165
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Treating Maternal Depression in an Urban Community-Based Pediatric Asthma Clinic: Targeting Maternal Mood, Child Asthma Outcomes, and Health Disparities
在城市社区小儿哮喘诊所治疗孕产妇抑郁症:针对孕产妇情绪、儿童哮喘结果和健康差异
- 批准号:
10723233 - 财政年份:2023
- 资助金额:
$ 6.7万 - 项目类别:
Treating Respiratory Emergencies in Children (T-RECS) Feasibility Study
治疗儿童呼吸急症 (T-RECS) 可行性研究
- 批准号:
10370791 - 财政年份:2023
- 资助金额:
$ 6.7万 - 项目类别:
Defining and treating peripheral nervous system dysfunction in Cln1 disease
Cln1 疾病周围神经系统功能障碍的定义和治疗
- 批准号:
10597696 - 财政年份:2022
- 资助金额:
$ 6.7万 - 项目类别:
Defining and treating peripheral nervous system dysfunction in Cln1 disease
Cln1 疾病周围神经系统功能障碍的定义和治疗
- 批准号:
10428174 - 财政年份:2022
- 资助金额:
$ 6.7万 - 项目类别:
Self-Supporting Nasopharyngeal Airway (ssNPA) Treating Upper Airway Obstruction in Hypotonia
自支撑鼻咽气道 (ssNPA) 治疗肌张力低下的上气道阻塞
- 批准号:
10707489 - 财政年份:2021
- 资助金额:
$ 6.7万 - 项目类别: